Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,200 DKK | +0.84% | -0.84% | -9.79% |
Mar. 04 | FDA Extends Review of Zevra's Arimoclomol by Three Months | DJ |
Feb. 21 | Orphazyme A/S acquired an additional unknown minority stake in CombiGene AB (OM:COMBI). | CI |
- Stock
- Equities
- Stock Orphazyme A/S - Nasdaq Copenhagen
- News Orphazyme A/S